EPCAM and metabolic dysfunction-associated steatotic liver disease: Furthermore, the amounts of EpCAM and ITGA3 in EVs were positively associated with the progression of MASLD, which suggests the use of liver‐derived EVs as potential biomarkers for MASLD.